Humacyte (HUMA)

• Market cap: $170M
• 1 day: -6.44%
• 5 days: -5.4%
• 1 month: -21.05%
• 3 months: -25.58%
• 6 months: -36.93%
• Year to date: -35.31%
• 1 year: -74.47%
• 5 years: -93.67%
• 10 years: -93.48%
• Sector: Healthcare
• Industry: Biotechnology

About: Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Employees: 184